Helena Ban Frangež

Dr. Helena Ban Frangež

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
Valentina Lucia La RosaValentina Lucia La Rosa
Valentina Lucia La Rosa
ARAgnese Maria Chiara Rapisarda
Agnese Maria Chiara Rapisarda
GVGaetano Valenti
Gaetano Valenti
FSFabrizio Sapia
Fabrizio Sapia
SVSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
Endometriosis is one of the most common gynecological diseases and affects ~10% of women in reproductive age. The most common clinical signs of endometriosis are menstrual irregularities, chronic pelvic pain (CPP), dysmenorrhea, dyspareunia and infertility. Symptoms of endometriosis often affect psychological and social functioning of patients. For this reason, endometriosis is considered as a disabling condition that may significantly compromise social relationships, sexuality and mental health. Considering this point, the aim of this narrative review is to elucidate the impact of anxiety and depression in the management of women with endometriosis. Psychological factors have an important role in determining the severity of symptoms, and women who suffer from endometriosis report high levels of anxiety, depression and other psychiatric disorders. In addition, endometriosis is one of the most important causes of CPP; women with endometriosis suffer from a wide range of pelvic pain such as dysmenorrhea, dyspareunia, nonmenstrual (chronic) pelvic pain, pain at ovulation, dyschezia and dysuria. Several studies have underlined the influence of CPP on quality of life and psychological well-being of women with endometriosis. Data suggest that the experience of pelvic pain is an important component of endometriosis and may significantly affect emotive functioning of affected women. It has been demonstrated that high levels of anxiety and depression can amplify the severity of pain. Further studies are needed to better understand the relationship between psychological factors and perception of pain. Treatment of endometriosis may be hormonal or surgical. Surgery is the primary treatment for more severe forms of endometriosis. There are few data in the literature about the influence of psychological factors and psychiatric comorbidities on the effectiveness of treatments. It is important to evaluate the presence of previous psychiatric diseases in order to select the most appropriate treatment for the patient.

1 June 2017 in Medical Hypotheses
Verified
Journal Article
Closed access
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
SVSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
FSFrancesca Maria Salmeri
Francesca Maria Salmeri
OTOnofrio Triolo
Onofrio Triolo
HFHelena Ban Frangež
Helena Ban Frangež
VSVincenza Sofo
Vincenza Sofo

30 October 2019 in Gynecological Endocrinology
Verified
Journal Article
Closed access
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
FSFrancesca Maria Salmeri
Francesca Maria Salmeri
HFHelena Ban Frangež
Helena Ban Frangež
FGFabio Ghezzi
Fabio Ghezzi
EVEda Vrtačnik-Bokal
Eda Vrtačnik-Bokal
RGRoberta Granese
Roberta Granese
Endometriosis is an estrogen-dependent disease defined by the presence and growth of functional endometrial-like tissue, glands and stroma, outside the uterine cavity. Macrophages are broadly classified into pro-inflammatory M1 macrophages, and M2 macrophages, which have selective anti-inflammatory and pro-fibrotic activities and are able to induce immunotolerance and angiogenesis. Based on these elements, the aim of our study was to evaluate CD14+CD68+CD197+CD80+ M1 and CD14+CD68+CD163+CD206+ M2 macrophages in tissue samples from ovarian endometriomas of women affected by endometriosis at different stages of the disease. For each patient, we collected a biological sample of the cyst (ovarian endometriomas for cases and ovarian functional cyst for controls) during laparoscopy. We found that the number of both M1 and M2 macrophages was significantly higher in endometriosis group than controls, regardless of stage (p < .0001 for each stage versus controls). Moreover, our data analysis shows a trend in progressive decrease of M1 macrophages from stage I to stage IV; on the contrary, M2 macrophages show a specular trend compared to M1 macrophages, with a progressive increase from stage I to stage IV. This may contribute to the pro-inflammatory microenvironment in the early stages of the disease, and to the pro-fibrotic activity of the advanced stages.

Verified
Journal Article
Open access
PDF file
SOSanja Ozimic
Sanja Ozimic
HFHelena Ban Frangež
Helena Ban Frangež
MSMartin Stimpfel
Martin Stimpfel
The cryopreservation of human spermatozoa has been an option for patients undergoing chemo or radiotherapies since the late 1950s. Presently, there are different techniques for the cryopreservation of spermatozoa. The most commonly used techniques are programmable slow freezing and freezing on liquid nitrogen vapors, while the use of vitrification is still not accepted as clinically relevant. Although there have been many improvements, the ideal technique for achieving better post-thaw sperm quality continues to be a mystery. A major obstacle during cryopreservation is the formation of intracellular ice crystals. Cryodamage generated by cryopreservation causes structural and molecular alterations in spermatozoa. Injuries can happen because of oxidative stress, temperature stress, and osmotic stress, which then result in changes in the plasma membrane fluidity, motility, viability, and DNA integrity of the spermatozoa. To prevent cryodamage as much as possible, cryoprotectants are added, and in some clinical trial cases, even antioxidants that may improve post-thaw sperm quality are added. This review discusses cryopreservation techniques, cryodamage on molecular and structural levels, and cryoprotectants. It provides a comparison of cryopreservation techniques and describes recent advances in those techniques.

1 November 2010 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
TTT. Tomaževič
T. Tomaževič
HFHelena Ban Frangež
Helena Ban Frangež
IVI. Virant-Klun
I. Virant-Klun
IVI. Verdenik
I. Verdenik
BPB. Požlep
B. Požlep
EVE. Vrtačnik-Bokal
E. Vrtačnik-Bokal

1 December 2007 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
TTT. Tomaževič
T. Tomaževič
HFHelena Ban Frangež
Helena Ban Frangež
MRM. Ribič-Pucelj
M. Ribič-Pucelj
TPTanja Premru-Sršen
Tanja Premru-Sršen
IVI. Verdenik
I. Verdenik